Professional Documents
Culture Documents
DOI: 10.1183/09031936.00070812
CopyrightERS 2013
ERJ Open articles are open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 3.0
ABSTRACT: Investigation of contacts of patients with tuberculosis (TB) is a priority for TB control
in high-income countries, and is increasingly being considered in resource-limited settings. This
review was commissioned for a World Health Organization Expert Panel to develop global contact
investigation guidelines.
We performed a systematic review and meta-analysis of all studies reporting the prevalence of
TB and latent TB infection, and the annual incidence of TB among contacts of patients with TB.
After screening 9,555 titles, we included 203 published studies. In 95 studies from low- and
middle-income settings, the prevalence of active TB in all contacts was 3.1% (95% CI 2.24.4%,
I2599.4%), microbiologically proven TB was 1.2% (95% CI 0.91.8%, I2595.9%), and latent TB
infection was 51.5% (95% CI 47.155.8%, I2598.9%). The prevalence of TB among household
contacts was 3.1% (95% CI 2.14.5%, I2598.8%) and among contacts of patients with multidrugresistant or extensively drug-resistant TB was 3.4% (95% CI 0.812.6%, I2595.7%). Incidence was
greatest in the first year after exposure. In 108 studies from high-income settings, the prevalence
of TB among contacts was 1.4% (95% CI 1.11.8%, I2598.7%), and the prevalence of latent
infection was 28.1% (95% CI 24.232.4%, I2599.5%). There was substantial heterogeneity among
published studies.
Contacts of TB patients are a high-risk group for developing TB, particularly within the first year.
Children ,5 yrs of age and people living with HIV are particularly at risk. Policy recommendations
must consider evidence of the cost-effectiveness of various contact tracing strategies, and also
incorporate complementary strategies to enhance case finding.
KEYWORDS: Contact tracing, early diagnosis, human, Mycobacterium tuberculosis, systematic
review, tuberculosis
140
VOLUME 41 NUMBER 1
AFFILIATIONS
*Woolcock Institute of Medical
Research, University of Sydney,
#
Centenary Institute of Cancer
Medicine and Cell Biology, University
of Sydney,
"
Discipline of Medicine, Sydney
Medical School, University of
Sydney, and
+
Dept of Respiratory Medicine,
Liverpool Hospital, Sydney, Australia.
CORRESPONDENCE
G.J. Fox
Woolcock Institute of Medical
Research
University of Sydney
431 Glebe Point Road
Glebe
Sydney 2037
Australia
E-mail: greg.fox@sydney.edu.au
Received:
May 03 2012
Accepted after revision:
Aug 10 2012
First published online:
Aug 30 2012
TUBERCULOSIS
141
TUBERCULOSIS
Hand searching:
308 additional titles identified from hand
searching conference abstract books and
International Journal of Tuberculosis and
Lung Diseases
Literature search:
Databases: PubMed, EMBASE, LILACS,
Web of Science
9555 articles identified
Prevalence
studies
Incidence
studies
Prevalence
studies
Incidence
studies
87 TB studies
92 LTBI studies
29 TB
incidence studies
71 TB studies
76 LTBI studies
25 TB
incidence studies
Household studies
52 TB studies
73 LTBI studies
FIGURE 1.
Flow diagram for study selection. TB: tuberculosis; LTBI: latent tuberculosis infection.
VOLUME 41 NUMBER 1
TABLE 1
TUBERCULOSIS
Prevalence of active tuberculosis (TB) among contacts in lowmiddle- and high-income countries
Proportion %
95% CI
t2
I2
878724
3.1
2.24.4
2.18
99.4
43960
3.3
2.25.1
2.04
98.5
1526
5.4
2.212.4
1.14
95.5
95.7
Included
Contacts with
Contacts
studies
active TB
screened
All#
71
24799
44
1415
90
Lowmiddle income
All ages
149
5584
3.4
0.812.6
2.88
Household contacts
68
22390
858422
3.1
2.14.5
2.35
98.8
70
22458
860638
3.1
2.24.4
2.22
98.8
0.00
34
1492
2.2
1.63.0
96
391
21.6
8.844.1
2.04
92.3
f5 yrs
21
754
5112
10.0
5.018.9
2.35
97.8
514 yrs
155
1643
8.4
2.822.6
2.51
92.5
o15 yrs
11
127
3614
3.2
2.05.3
0.53
87.1
All"
87
5058
308048
1.4
1.11.8
1.48
98.7
27
1704
72936
3.3
2.24.8
1.08
98.3
554
0.0
0.00
99.9
98.2
High income
All ages
Household contacts
29
2047
56221
3.0
2.04.4
1.09
45
3053
127699
1.9
1.32.7
1.42
98.7
73
15607
0.4
0.20.6
0.30
79.9
15
133
11.4
7.018.0
0.00
9.0
10
212
4057
4.7
3.46.4
0.18
79.0
514 yrs
253
5665
2.9
1.75.1
0.56
95.5
o15 yrs
507
17867
2.3
1.14.8
1.19
99.0
Data are presented as n, unless otherwise stated. XDR: extensively drug resistant; MDR: multidrug resistant. Countries were classified according to World Bank Income
Gross National Income per capita: low income (f$1,005 per yr); lower-middle income ($1,006 to $3,975 per yr); upper-middle income ($3,976 to $12,275 per yr); high
income (o$12,276 per yr) [22]. #: [9, 32101]; ": [10, 30, 31, 102184]. Refer to supplementary material for outcomes of individual included studies.
for which data were available [22]. Studies were also stratified
by WHO region. We stratified outcomes according to proximity
of exposure (household, close and casual), age group, HIV
status of the index patient, HIV status of the contact, smear
positivity of the index patient and a diagnosis of MDR-TB in the
index patient. We stratified outcomes according to whether
contacts and index patients participating in contact investigation were foreigners or born locally. We planned to assess the
risk of bias of studies at the level of outcome level. We also
planned to determine whether study design was independently
associated with yield and, if so, to conduct separate analyses for
cross-sectional and cohort studies. More detailed definitions of
the diagnostic and stratification criteria are included in the
supplementary material.
Summary measures and methods of analysis
For each study, incidence rate was calculated as the number of
incident cases per year divided by the population at risk and
prevalence was calculated as the number of prevalent cases
expressed as a proportion of the size of the at-risk population.
Asymptotic 95% confidence intervals were calculated using the
method of FLEISS [23].
VOLUME 41 NUMBER 1
143
TUBERCULOSIS
2500
Annual incidence rate of TB
cases per 100000yr-1
Lowmiddle-income
countries#
High-income countries
2000
*
1500
*
1000
500
0
1
2
3
4
Follow-up after exposure to index patient yrs
FIGURE 2.
follow-up, according to country income. World Bank Income Gross National Income
per capita: low income (f$1,005 per yr); lower-middle income ($1,006 to $3,975
per yr); upper-middle income ($3,976 to $12,275 per yr); high income (o$12,276
per yr) [22]. *: p,0.05, statistically significant difference between contacts from
high compared to lowmiddle-income countries. #: [25, 32, 3650, 102106, 110
127, 185193]; ": [33, 34, 103105, 129, 135, 136, 140, 143, 144, 148151, 153,
157, 163, 164, 172, 194202]. Refer to the supplementary material for complete
details of outcomes, estimates of heterogeneity and outcomes of individual
included studies.
VOLUME 41 NUMBER 1
TUBERCULOSIS
TABLE 2
Prevalence of latent tuberculosis (TB) infection in the contacts of TB patients in lowmiddle- and high-income countries
Proportion %
95% CI
t2
I2
60557
51.5
47.155.8
0.58
98.9
33875
52.9
48.956.8
0.32
97.7
2376
45.7
38.752.9
0.22
90.9
Included
Contacts with
Contacts
studies
active TB
screened
All#
76
35788
51
19003
12
1138
Lowmiddle income
All ages
431
684
61.3
39.179.6
1.21
95.2
Household contacts
73
23577
49512
45.4
40.750.2
0.69
98.4
73
23577
49643
45.3
40.650.1
0.69
98.4
123
247
53.5
40.666.0
0.36
71.4
f5 yrs
33
5102
12389
35.5
30.341.1
0.42
96.6
514 yrs
21
6587
11123
53.1
42.063.9
1.05
98.6
o15 yrs
10
11980
14057
65.3
35.586.5
3.80
99.6
All"
92
79511
284505
28.1
24.232.4
0.99
99.5
34
25910
78784
34.8
27.642.7
0.96
99.1
131
363
36.0
31.241.0
0.00
High income
All ages
287
554
52.6
49.555.7
0.00
Household contacts
33
20960
67175
30.0
21.340.5
1.80
99.6
29
20213
68738
28.0
18.939.4
1.96
99.6
5779
27383
18.7
11.828.5
0.52
99.4
28
151
25.0
11.446.4
0.53
86.6
f5 yrs
17
2093
6900
16.3
9.227.0
1.73
99.2
514 yrs
10
1,407
4,871
18.4
11.827.5
0.64
98.4
o15 yrs
6221
12633
41.9
30.554.2
0.50
99.4
Data are presented as n, unless otherwise stated. XDR: extensively drug resistant; MDR: multidrug resistant. World Bank Income Gross National Income per capita: low
income (f$1,005 per yr); lower-middle income ($1,006 to $3,975 per yr); upper-middle income ($3,976 to $12,275 per yr); high income (o$12,276 per yr) [22]. #: [9, 32,
34, 3639, 4143, 48, 49, 52, 55, 5760, 6267, 69, 71, 73, 74, 7779, 81, 8389, 91, 9395, 97101, 185187, 194196, 199201 203215]; ": [10, 28, 30, 31, 102, 103,
105, 107, 109111, 115, 116, 119, 121125, 128138, 142145, 147157, 159184, 188, 189, 193, 202, 216233].
VOLUME 41 NUMBER 1
145
TUBERCULOSIS
TABLE 3
Prevalence of microbiologically proven tuberculosis (TB) in the contacts of TB patients in lowmiddle- and high-income
countries
Proportion %
95% CI
t2
I2
841721
1.2
0.91.8
1.00
95.9
10241
1.2
0.81.8
0.47
87.4
1317
1.9
0.84.5
0.53
89.7
82.7
Included
Contacts with
Contacts
studies
active TB
screened
All#
38
8633
17
150
35
Lowmiddle income
All ages
1056
0.2
0.00.8
0.00
Household contacts
36
8336
811231
1.4
1.02.1
1.16
97.9
37
8426
824541
1.4
1.02.1
1.14
97.8
12
1492
0.7
0.41.3
0.00
All"
21
264
45897
0.4
0.20.7
1.56
108
5970
0.7
0.31.9
1.08
97.6
554
0.0
0.00
99.9
High income
All ages
96.1
Household contacts
116
5459
1.4
0.82.5
0.33
92.6
14
187
30269
0.4
0.20.9
1.35
96.9
275
0.0
1.87
Data are presented as n, unless otherwise stated. XDR: extensively drug resistant; MDR: multidrug resistant. World Bank Income Gross National Income per capita: low
income (f$1,005 per yr); lower-middle income ($1,006 to $3,975 per yr); upper-middle income ($3,976 to $12,275 per yr); high income (o$12,276 per yr) [22].#: [9, 33,
34, 38, 4246, 54, 5658, 60, 62, 63, 6668, 7073, 75, 76, 79, 82, 84, 85, 88, 90, 91, 95, 97, 99101, 234]; ": [30, 31, 111113, 116, 119, 120, 122, 134, 135, 137, 138,
148150, 154, 165, 166, 170, 177].
146
VOLUME 41 NUMBER 1
TUBERCULOSIS
Screened Proportion %
n
(95% CI)
Country
288
683
345
231
434
1024
130
253
360
148
376
132
414
2381
109
105
3310
1213
129
1681
2679
200
174
317
184
283
1506
250
116
152
897
195
140
979
1200
408
401
1597
1918
531
461
13310
2060
256
43960
ALOUCH [72]
Nigeria
ALAVI [67]
Iran
AFONJA [82]
Kenya
ALOUCH [68]
Kenya
AZIA [45]
Pakistan
BAKIR [49]
Turkey
BEYERS [94]
South Africa
BOKHARI [83]
Pakistan
CARVALHO [32]
Brazil
CRAMPIN [43]
Malawi
EGSMOSE [42]
Kenya
GILPIN [34]
South Africa
GROUNDS [71]
Kenya
HILL [38]
Gambia
HUSSAIN [44]
Pakistan
KASAMBIRA [93]
South Africa
KILICASIAN [52]
Iran
KLAUSNER [57]
Dem. Rep. Congo
KUMAR [54]
India
LEWINSOHN [199]
Uganda
LIENHARDT [48]
Senegal
MARAIS [95]
South Africa
MTOMBENI [89]
Zimbabwe
NGUYEN [73]
Laos
NSANZUMUHIRE [72]
Kenya
NUNN [69]
Kenya
PADUNGCHAN [99]
Thailand
PAI [39]
India
POTHUKUCHI [53]
India
SALAZAR-VERGARA [97]
Philippines
SIA [101]
Philippines
SINFIELD [78]
Malawi
SINGH [52]
India
SOYSAL [100]
Turkey
SUGGARAVETSIRI [9]
Thailand
TELXEIRA [60]
Brazil
WHO [67]
Kenya
WARES [82]
Nepal
WHALEN [85]
Uganda
YAD [84]
Pakistan
ZACHARIAH [76]
Malawi
ZHANG [34]
China
DEL CORRAL [37]
Columbia
VAN ZYL [86]
South Africa
Overall
FIGURE 3.
10
15
20
25
30
35
Prevalence of active TB %
40
45
50
13.2 (9.617.8)
8.3 (6.410.5)
0.9 (0.22.7)
2.2 (0.85.3)
8.3 (6.011.4)
1.4 (0.82.3)
40.0 (31.649.0)
14.6 (10.619.7)
1.7 (0.73.8)
3.4 (1.38.1)
1.3 (0.53.3)
3.0 (1.08.15)
5.8 (3.88.6)
1.4 (1.02.0)
0.0 (0.14.2)
0.0 (0.14.4)
2.2 (1.72.8)
4.2 (3.25.5)
7.8 (4.014.2)
0.6 (0.31.1)
0.5 (0.30.9)
17.0 (12.223.1)
48.9 (41.356.6)
1.3 (0.43.4)
2.7 (1.06.6)
5.3 (3.18.8)
14.5 (12.816.4)
0.4 (0.02.6)
0.0 (0.14.0)
3.3 (1.27.9)
12.8 (10.0715.2)
22.6 (17.129.2)
5.0 (2.210.4)
1.3 (0.72.3)
3.8 (2.85.0)
4.2 (2.56.7)
9.7 (7.113.2)
0.8 (0.51.4)
2.6 (1.93.4)
9.0 (6.811.8)
1.7 (0.83.5)
0.7 (0.60.8)
0.4 (0.20.8)
29.7 (24.335.8)
3.3 (2.25.1)
55
Forest plot of the prevalence of active tuberculosis (TB) among contacts of smear-positive TB in lowmiddle-income countries. The size of the symbols is
VOLUME 41 NUMBER 1
147
TUBERCULOSIS
Screened Proportion %
(95% CI)
n
Country
ANSARI [106]
UK
CAPEWELL [144]
UK
DASGUPTA [128]
Canada
EMERSON [117]
UK
GOLUB [181]
USA
GRZYBOWSKI [131]
Canada
HOME [116]
UK
HORTONEDA [136]
Spain
JERAB [174]
USA
JIN [154]
South Korea
KARALUS [157]
New Zealand
KIK [156]
The Netherlands
LIIPPO [112]
Finland
MADHI [138]
France
MARKS [10]
USA
NOERTJOJO [147]
Hong Kong
PAYNE [102]
UK
REICHLER [235]
USA
ROSE [175]
USA
RUBILAR [104]
UK
SPRINSON [176]
USA
SWAYNE [127]
USA
THOMAS [145]
UK
UNDERWOOD [139]
UK
VIDAL [111]
Spain
DEL CASTILLO OTERO [135]
Spain
VAN GEUNS [30]
The Netherlands
Overall
227
1582
200
1517
639
4355
873
723
33521
1223
461
715
609
91
6225
627
151
985
1096
647
11838
304
17
263
3071
823
153
72936
FIGURE 4.
10
15
20
25
30
35
40
Prevalence of active TB %
45
50
0.4 (0.02.8)
2.9 (2.23.9)
3.0 (1.26.7)
5.6 (4.56.9)
2.5 (1.54.1)
6.5 (5.87.3)
11.5 (9.513.8)
2.2 (1.33.7)
1.1 (1.01.2)
10.5 (8.912.4)
9.3 (6.912.4)
2.0 (1.13.4)
0.0 (0.010.78)
6.6 (2.714.4)
2.2 (1.82.6)
2.7 (1.64.4)
21.0 (15.028.5)
0.9 (0.51.8)
0.9 (0.51.7)
5.6 (4.07.7)
0.7 (0.60.9)
4.3 (2.47.4)
5.9 (0.330.8)
4.9 (2.78.5)
5.7 (5.06.6)
4.6 (3.36.3)
11.1 (6.817.4)
3.3 (2.24.8)
55
Forest plot of the prevalence of active tuberculosis (TB) among contacts of smear-positive TB in high-income countries. The size of the symbols is
TABLE 4
Prevalence of latent tuberculosis infection (LTBI) among foreign and locally born contacts in high-income countries#
Country of origin
95% CI
t2
I2
17.0
11824.0
0.28
98.5
1.0
39.2
30.049.3
0.24
97.9
3.39 (3.103.71)
Included
Contacts
Contacts
Proportion
studies
with LTBI
screened
1536
7576
1849
4298
OR (95% CI)
p-value
,0.0001
Data are presented as n, unless otherwise stated. #: [10, 107, 133, 145, 168, 189, 216].
148
VOLUME 41 NUMBER 1
TABLE 5
TUBERCULOSIS
Country
GAENSBAUER [149]
LOFY [169]
Location of contact
Contacts tested
Ireland
268
6.7
NA
USA
Homeless facilities
425
3.1
23.3
MARIENAU [164]
USA
Aeroplane flight
861
24
CONOVER [221]
USA
Methadone clinic
393
NA
22.3
USA
344
NA
29.8
DAVIDOW [166]
USA
Workplaces
724
0.2
22.0
Data are presented as n, unless otherwise stated. TB: tuberculosis; LTBI: latent tuberculosis infection; NA: not available.
STATEMENT OF INTEREST
None declared.
ACKNOWLEDGEMENTS
VOLUME 41 NUMBER 1
149
TUBERCULOSIS
REFERENCES
1 World Health Organization. Global tuberculosis control 2011.
Geneva, WHO, 2011.
2 World Health Organization, Stop TB Partnership. The Stop
TB Strategy: Building on and enhancing DOTS to meet the
TB-related Millennium Development Goals. Geneva, WHO,
2006.
3 Stop TB Partnership. The Global Plan to Stop 20112015.
Transforming the fight towards elimination of tuberculosis.
Geneva, WHO, 2010.
4 Riechler HL. Contacts of tuberculosis patients in high-incidence
countries. Int J Tuberc Lung Dis 2003; 7: Suppl. 3, S333S336.
5 Greenaway C, Palayew M, Menzies D. Yield of casual contact
investigation by the hour. Int J Tuberc Lung Dis 2003; 7: Suppl. 3,
S479S485.
6 Fok A, Numata Y, Schulzer M, et al. Risk factors for clustering of
tuberculosis cases: a systematic review of population-based
molecular epidemiology studies. Int J Tuberc Lung Dis 2008; 12:
480492.
7 Kenyon TA, Valway SE, Walter WI, et al. Transmission of
multidrug-resistant Mycobacterium tuberculosis during a long
airplane flight. N Engl J Med 1996; 334: 933938.
8 Yim J, Selvaraj P. Genetic susceptibility in tuberculosis.
Respirology 2010; 15: 241256.
9 Suggaravetsiri P, Yanai H, Chongsuvivatwong V, et al.
Integrated counseling and screening for tuberculosis and HIV
among household contacts of tuberculosis patients in an
endemic area of HIV infection: Chiang Rai, Thailand. Int J
Tuberc Lung Dis 2003; 7: Suppl. 3, S424S431.
10 Marks SM, Taylor Z, Qualls NL, et al. Outcomes of contact
investigations of infectious tuberculosis patients. Am J Respir Crit
Care Med 2000; 162: 20332038.
11 Control and prevention of tuberculosis in the United Kingdom:
code of practice 2000. Joint Tuberculosis Committee of the British
Thoracic Society. Thorax 2000; 55: 887901.
12 Hwang TJ, Ottmani S, Uplekar M. A rapid assessment of
prevailing policies on tuberculosis contact investigation. Int J
Tuberc Lung Dis 2011; 15: 16201623.
13 World Health Organization. International Standards for
Tuberculosis Care: Diagnosis, Treatment, Public Health. The
Hague, Tuberculosis Coalition for Technical Assistance, 2006.
14 World Health Organization. WHO Three Is Meeting. Geneva,
Switzerland, 2008.
15 World Health Organization. Recommendations for investigating
contacts of persons with infectious tuberculosis in low and
middle-income countries. WHO/HTM/TB/2012.9. Geneva,
WHO, 2012.
16 Morrison J, Pai M, Hopewell PC. Tuberculosis and latent
tuberculosis infection in close contacts of people with pulmonary
tuberculosis in low-income and middle-income countries: a
systematic review and meta-analysis. Lancet Infect Dis 2008; 8:
359368.
17 Guyatt GHG, Oxman A, Vist G, et al. GRADE: an emerging
consensus on rating quality of evidence and strength of
recommendations. BMJ 2008; 336: 924926.
18 Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement
for reporting systematic reviews and meta-analyses of studies
that evaluate healthcare interventions: explanation and elaboration. BMJ 2009; 339: b2700.
150
VOLUME 41 NUMBER 1
19 Fox GJ, Dobler CC, Marks GB. Active case finding in contacts of
people with tuberculosis. Cochrane Database Syst Rev 2011; 9:
CD008477.
20 Liu E, Cheng S, Wang X, et al. A systematic review of the
investigation and management of close contacts of tuberculosis
in China. J Public Health (Oxf) 2010; 32: 461466.
21 Mulder C, Klinkenberg E, Manissero D. Effectiveness of
tuberculosis contact tracing among migrants and the foreignborn population. Euro Surveill 2009; 14: 19153.
22 The World Bank. Data. How we Classify Countries. http://data.
worldbank.org/about/country-classifications Date last accessed:
November 1, 2012.
23 Fleiss J, ed. Statistical methods for rates and proportions. 2nd
Edn. New York, John Wiley & Sons, 1981; pp. 1415.
24 Hamza TH, van Houwelingen HC, Stijnen T. The binomial
distribution of meta-analysis was preferred to model withinstudy variability. J Clin Epidemiol 2008; 61: 4151.
25 The World Bank. Data. Incidence of tuberculosis per 100,000
people. http://data.worldbank.org/indicator/SH.TBS.INCD Date
last accessed: November 1, 2012.
26 Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557560.
27 Riley RD, Higgins JPT, Deeks JJ. Interpretation of random effects
meta-analyses. BMJ 2009; 342: d549.
28 Mixides G, Shende V, Teeter LD, et al. Number of negative acidfast smears needed to adequately assess infectivity of patients
with pulmonary tuberculosis. Chest 2005; 128: 108115.
29 Diel R, Loddenkemper R, Meywald-Walter K, et al. Comparative
performance of tuberculin skin test, QuantiFERON-TB-Gold In
Tube assay, and T-Spot.TB test in contact investigations for
tuberculosis. Chest 2009; 135: 10101018.
30 van Geuns HA, Meijer J, Styblo K. Results of contact examination in Rotterdam, 19671969. Bull Int Union Tuberc 1975; 50:
107121.
31 Snider DE Jr, Kelly GD, Cauthen GM, et al. Infection and disease
among contacts of tuberculosis cases with drug-resistant
and drug-susceptible bacilli. Am Rev Respir Dis 1985; 132:
125132.
32 Carvalho AC, DeRiemer K, Nunes ZB, et al. Transmission of
Mycobacterium tuberculosis to contacts of HIV-infected tuberculosis patients. Am J Respir Crit Care Med 2001; 164: 21662171.
33 Zhang X, Wei X, Zou G, et al. Evaluation of active tuberculosis
case finding through symptom screening and sputum microscopy of close contacts in Shandong, China. Trop Med Int Health
2011.
34 Gilpin TP, Hammond M. Active case-finding for the whole
community or for tuberculosis contacts only? S Afr Med J 1987;
72: 260262.
35 Becerra MC, Appleton SC, Franke MF, et al. Tuberculosis burden
in households of patients with multidrug-resistant and extensively drug-resistant tuberculosis: a retrospective cohort study.
Lancet 2011; 377: 147152.
36 Lemos AC, Matos ED, Pedral-Sampaio DB, et al. Risk of
tuberculosis among household contacts in Salvador, Bahia.
Braz J Infect Dis 2004; 8: 424430.
37 del Corral H, Paris SC, Marin ND, et al. IFN-gamma response to
Mycobacterium tuberculosis, risk of infection and disease in
household contacts of tuberculosis patients in Colombia. PLoS
One 2009; 4: e8257.
38 Hill PC, Jackson-Sillah DJ, Fox A, et al. Incidence of tuberculosis
and the predictive value of ELISPOT and Mantoux tests in
Gambian case contacts. PLoS Med 2008; 3: e1379.
39 Pai M, Joshi R, Dogra S, et al. T-cell assay conversions and
reversions among household contacts of tuberculosis patients in
rural India. Int J Tuberc Lung Dis 2009; 13: 8492.
40 Ramakrishnan CV, Andrews RH, Devadatta S, et al. Influence of
segregation to tuberculous patients for one year on the attack
EUROPEAN RESPIRATORY JOURNAL
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
TUBERCULOSIS
151
TUBERCULOSIS
VOLUME 41 NUMBER 1
TUBERCULOSIS
VOLUME 41 NUMBER 1
153
TUBERCULOSIS
VOLUME 41 NUMBER 1
202 [Tuberculin skin testing of close contacts: recent or longstanding infection?]. Can Commun Dis Rep 2006; 32: 133140.
203 Nakaoka H, Lawson L, Squire SB, et al. Risk for tuberculosis
among children. Emerg Infect Dis 2006; 12: 13831388.
204 Rakotosamimanana N, Raharimanga V, Andriamandimby SF,
et al. Variation in gamma interferon responses to different
infecting strains of Mycobacterium tuberculosis in acid-fast
bacillus smear-positive patients and household contacts in
Antananarivo, Madagascar. Clin Vaccine Immunol 2010; 17:
10941103.
205 Narain R, Nair SS, Rao GR, et al. Distribution of tuberculous
infection and disease among households in a rural community.
Bull World Health Organ 1966; 34: 639654.
206 Radhakrishna S, Frieden TR, Subramani R, et al. Additional risk
of developing TB for household members with a TB case at
home at intake: a 15-year study. Int J Tuberc Lung Dis 2007; 11:
282288.
207 Ramakrishnan CV, Andrews RH, Devadatta S, et al. Prevalence
and early attack rate of tuberculosis among close family contacts
of tuberculous patients in South India under domiciliary
treatment with isoniazid plus PAS or isoniazid alone. Bull
World Health Organ 1961; 26: 361407.
208 Lienhardt C, Fielding K, Sillah J, et al. Risk factors for
tuberculosis infection in sub-Saharan Africa: a contact study in
The Gambia. Am J Respir Crit Care Med 2003; 168: 448455.
209 Lutong L, Bei Z. Association of prevalence of tuberculin
reactions with closeness of contact among household contacts
of new smear-positive pulmonary tuberculosis patients. Int J
Tuberc Lung Dis 2000; 4: 275277.
210 Almeida LM, Barbieri MA, Da Paixao AC, et al. Use of purified
protein derivative to assess the risk of infection in children in
close contact with adults with tuberculosis in a population with
high Calmette-Guerin bacillus coverage. Pediatr Infect Dis J 2001;
20: 10611065.
211 Raqib R, Kamal SM, Rahman MJ, et al. Use of antibodies in
lymphocyte secretions for detection of subclinical tuberculosis
infection in asymptomatic contacts. Clin Diagn Lab Immunol 2004;
11: 10221027.
212 Hussain R, Talat N, Shahid F, et al. Biomarker changes associated
with Tuberculin Skin Test (TST) conversion: a two-year longitudinal follow-up study in exposed household contacts. PLoS
One 2009; 4: e7444.
213 Madico G, Gilman RH, Checkley W, et al. Community infection
ratio as an indicator for tuberculosis control. Lancet 1995; 345:
416419.
214 Aziz N, Hasan S, Munir M, et al. Risk to household contacts of
tuberculous patients based on Mantoux test and antibody titre.
J Ayub Med Coll Abbottabad 2008; 20: 4750.
215 Hesseling AC, Mandalakas AM, Kirchner HL, et al.
Highly discordant T cell responses in individuals with
recent exposure to household tuberculosis. Thorax 2009; 64:
840846.
216 Diel R, Loddenkemper R, Meywald-Walter K, et al. Comparative
performance of tuberculin skin test, QuantiFERON-TB-Gold In
Tube assay, and T-Spot.TB test in contact investigations for
tuberculosis. Chest 2009; 135: 10101018.
217 Anibarro L, Trigo M, Villaverde C, et al. Tuberculin skin test and
interferon-gamma release assay show better correlation after the
tuberculin window period in tuberculosis contacts. Scand J
Infect Dis 2011; 43: 424429.
218 Miller FJ. Work of a tuberculosis contact clinic for young
children, 19415. BMJ 1947; 2: 9194.
219 Johnson H, Lee B, Doherty E, et al. Tuberculin sensitivity and the
BCG scar in tuberculosis contacts. Tuber Lung Dis 1995; 76:
122125.
220 Ward LJ, Hughes SE, Grabau JC. The evaluation of schoolbased contact investigations in New York State, exclusive of
EUROPEAN RESPIRATORY JOURNAL
TUBERCULOSIS
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
New York City, 19972001. J Public Health Manag Pract 2004; 10:
308315.
Zaki MH, Lyons HA, Robins AB, et al. Tuberculin sensitivity.
Contacts of tuberculosis patients. NY State J Med 1976; 76:
21382143.
Conover C, Ridzon R, Valway S, et al. Outbreak of multidrugresistant tuberculosis at a methadone treatment program. Int J
Tuberc Lung Dis 2001; 5: 5964.
Andre M, Ijaz K, Tillinghast JD, et al. Transmission network
analysis to complement routine tuberculosis contact investigations. Am J Public Health 2007; 97: 470477.
Cauthen GM, Dooley SW, Onorato IM, et al. Transmission of Mycobacterium tuberculosis from tuberculosis patients
with HIV infection or AIDS. Am J Epidemiol 1996; 144:
6977.
Cook VJ, Sun SJ, Tapia J, et al. Transmission network analysis in
tuberculosis contact investigations. J Infect Dis 2007; 196:
15171527.
Centers for Disease Control and Prevention. Transmission of
Mycobacterium tuberculosis associated with failed completion of
treatment for latent tuberculosis infection Chickasaw County,
Mississippi, June 1999March 2002. MMWR Morb Mortal Wkly
Rep 2003; 52: 222224.
Centers for Disease Control and Prevention.: Cluster of
tuberculosis cases among exotic dancers and their close contacts
Kansas, 19942000. MMWR Morb Mortal Wkly Rep 2001; 50:
291293.
Johnsen C. Tuberculosis contact investigation: two years of
experience in New York City correctional facilities. Am J Infect
Control 1993; 21: 14.
Ames WR, Miles HC. Apparent decline in tuberculous infection among household associates of sputum-positive cases
of tuberculosis. Am J Public Health Nations Health 1950; 40:
143150.
Chapman JS, Dyerly MD. Social and other factors in intrafamilial transmission of tuberculosis. Am Rev Respir Dis 1964; 90:
4860.
Greenberg HB, Trachtman L, Thompson DH. Investigating the
contacts and suspected contacts of tuberculous patients in New
Orleans. South Med J 1977; 70: 829830.
Asghar RJ, Patlan DE, Miner MC, et al. Limited utility of namebased tuberculosis contact investigations among persons using
illicit drugs: results of an outbreak investigation. J Urban Health
2009; 86: 776780.
LoBue PA, LeClair JJ, Moser KS. Contact investigation for cases
of pulmonary Mycobacterium bovis. Int J Tuberc Lung Dis 2004; 8:
868872.
Beyers N. Case finding in children in contact with adults in the
house with TB. Int J Tuberc Lung Dis 2003; 7: 10131014.
Reichler MR, Reves R, Bur S, et al. Treatment of latent
tuberculosis infection in contacts of new tuberculosis cases in
the United States. South Med J 2002; 95: 414420.
Begg CB, Mazumdar M. Operating characteristics of a rank
correlation test for publication bias. Biometrics 1994; 50: 10881101.
Egger M, Davey Smith G, Schneider M, et al. Bias in metaanalysis detected by a simple, graphical test. BMJ 1997; 315:
629634.
Kranzer K, Houben RM, Glynn JR, et al. Yield of HIV-associated
tuberculosis during intensified case finding in resource-limited
settings: a systematic review and meta-analysis. Lancet Infect Dis
2010; 10: 93102.
World Health Organization Stop TB Partnership Childhood TB
Subgroup. Chapter 4: childhood contact screening and management. Int J Tuberc Lung Dis 2007; 11: 1215.
Veen J. Microepidemics of tuberculosis: the stone-in-the-pond
principle. Tuber Lung Dis 1992; 73: 7376.
VOLUME 41 NUMBER 1
155
TUBERCULOSIS
156
VOLUME 41 NUMBER 1